Anti-tumor workshop passed GMP certification
Renamed as Heilongjiang Fuhe Pharmaceutical Group Co., Ltd
Build a self operated business team
Investment and construction of a new raw material factory covering an area of 140000 square meters
Fuhe Huaxing Pharmaceutical achieved a revenue of 370 million yuan and a total profit of 75 million yuan
Investing in the construction of Beijing Lihe Pharmaceutical Production Base in Beijing Economic and Technological Development Zone
Formally renamed as Heilongjiang Fuhe Huaxing Pharmaceutical Group Co., Ltd
Domestically leading the development of a national second-class asthma relief drug, doxorubicin (Ansema) ®), Becoming the manufacturer with the most complete range of Doxophylline dosage forms in China
Renamed as Heilongjiang Zhaodong Huaxing Pharmaceutical Co., Ltd., it was one of the first 40 joint-stock reform enterprises in the province at that time
Zhaodong Pharmaceutical Factory Established